Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DR26FKKC2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $100,474
Award facts
- Contract value 100% obligated
- $100,474.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $100,474.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement competition. DMS Pharmaceutical Group was selected as the awardee based on its competitive capability and performance history supplying specialized pharmaceutical products to Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent contract, awarded on November 13, 2025, with a $499.999 billion ceiling value and extending through December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals, biologics, and medical consumables to support military healthcare operations globally. As a prime vendor contractor under this strategic initiative, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, fulfilling diverse and specialized medication requirements for Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FKKC2?
SPE2DR26FKKC2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FKKC2 worth?
The government has obligated $100,474 on SPE2DR26FKKC2.
Is contract SPE2DR26FKKC2 an order under another contract?
Yes. SPE2DR26FKKC2 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKC2 competed?
The extent of competition for SPE2DR26FKKC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award